Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oxford Technology 3 VCT is a UK-based Venture Capital Trust focused on investing in early-stage, high-growth technology and life science companies, many of which are spin-outs from the University of Oxford. The trust aims to provide long-term capital appreciation by supporting innovative startups in sectors such as biotechnology, healthcare diagnostics, and advanced engineering. Managed by Oxford Technology Management, it typically maintains a portfolio of companies ranging from pre-revenue startups to those with commercialized products. The VCT is listed on the London Stock Exchange and provides tax-efficient investment opportunities for UK taxpayers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oxford Technology 3 VCT.